Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion

Clinical Chemistry

Volumn 52, Issue 4, 2006, Pages 701-707

  Floderus, Ylva ^a   Sardh, Eliane ^b   Möller, Christer ^c,d   Andersson, Claes ^c,d   Rejkjaer, Lillan ^c,d   Andersson, Dan E H ^b   Harper, Pauline ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

^c Zymenex AS   (Denmark)

^d Karolinska University Hospital Huddinge ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PORPHOBILINOGEN; PORPHYRIN;

ACUTE INTERMITTENT PORPHYRIA; ADULT; ANALYTIC METHOD; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; ION EXCHANGE CHROMATOGRAPHY; KIDNEY CLEARANCE; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLITE; PATIENT MONITORING; PORPHYRIA; REMISSION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; URINARY EXCRETION; URINE LEVEL;

ADULT; AMINOLEVULINIC ACID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HETEROZYGOTE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PORPHOBILINOGEN; PORPHYRIA, ACUTE INTERMITTENT;

EID: 33645458741     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.058198     Document Type: Article

References (17)

1. Anderson KE, Sassa S, Bishop DF, Desnick RJ. Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, 8th ed., Vol. 2. New York: McGraw-Hill, 2001:2991-3062.
2. Thunell S, Harper P, Brock A, Petersen NE. Porphyrins, porphyrin metabolism, and porphyrias. II. Diagnosis and monitoring in the acute porphyrias. Scand J Clin Lab Invest 2000;60:541-59.
3. von und zu Fraunberg M, Pischik E, Udd L, Kauppinen R. Clinical and biochemical characteristics and genotype-phenotype correlation in 143 Finnish and Russian patients with acute intermittent porphyria. Medicine (Baltimore) 2005;84:35-47.
4. Thunell S. Porphyrins, porphyrin metabolism, and porphyrias. I. Update. Scand J Clin Lab Invest 2000;60:509-40.
5. Gorchein A, Webber R. delta-Aminolevulinic acid in plasma, cerebrospinal fluid, saliva, and erythrocytes: studies in normal, uremic, and porphyric subjects. Clin Sci 1987;72:103-12.
6. Miyagi K, Cardinal R, Bossenmaier I, Watson CJ. The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals. J Lab Clin Med 1971;78:683-95.
7. Lee C, Qiao X, Goeger DE, Anderson KE. Fluorometric measurement of 5-aminolevulinic acid in serum. Clin Chim Acta 2004;347:183-8.
8. Ford RE, Magera MJ, Kloke KM, Chezick PA, Fauq A, McConnell JP. Quantitative measurement of porphobilinogen in urine by stable-isotope dilution liquid chromatography-tandem mass spectrometry. Clin Chem 2001;47:1627-32.
9. Lord GA, Luo JL, Lim CK. Capillary zone electrophoresis/mass spectrometry of 5-aminolevulinic acid and porphobilinogen. Rapid Commun Mass Spectrom 2000;14:314-6.
10. Felitsyn NM, Henderson GN, James MO, Stacpoole PW. Liquid chromatography-tandem mass spectrometry method for the simultaneous determination of delta-ALA, tyrosine and creatinine in biological fluids. Clin Chim Acta 2004;350:219-30.
11. Floderus Y, Shoolingin-Jordan P, Harper P. Acute intermittent porphyria in Sweden. Molecular, functional, and clinical consequences of some new mutations found in the porphobilinogen deaminase gene. Clin Genet 2002;62:288-97.
12. Davis JR, Andelman SL. Urinary δ-aminolevulinic acid (ALA) levels in lead poisoning. Arch Environ Health 1967;15:53-9.
13. Mauzerall D, Granick S. The occurrence and determination of δ-aminolevulinic acid and porphobilinogen in urine. J Biol Chem 1956;219:435-46.
14. Bloom KE, Zaider EF, Morledge LJ, Poh-Fitzpatrick MB. Urinary porphyrin excretion in normal children and adults. Am J Kidney Dis 1991;18:483-9.
15. Jaffe M. Über den Niederschlag welchen Pikrinsäure in normalen Harn erzeugt und über eine neue Reaction des Kreatinins. Z Physiol Chem 1886;10:391-400.
16. Soonawalla ZF, Orug T, Badminton MN, Elder GH, Rhodes JM, Bramhall SR, et al. Liver transplantation as a cure for acute intermittent porphyria. Lancet 2004;363:705-6.
17. Wenger S, Meisinger V, Brucke T, Deecke L. Acute porphyric neuropathy during pregnancy-effect of hematin therapy. Eur Neurol 1998;39:187-8.